Though women have a lower risk of ventricular arrhythmias than do men, it still exceeds the threshold to justify a device.

Boston Scientific, Medtronic, Abbott and J&J unveiled new data for their PFA devices in tandem with the Heart Rhythm ...

Huxley Medical unveiled promising investigational data from the company's SANSA monitoring platform at the Heart Rhythm ...

The biggest names in cardiac care gathered in San Diego for the Heart Rhythm Society (HRS) 2025 Annual Meeting.

At least 26 million people worldwide have congestive heart failure, and heart failure itself is the leading cause of death ...

Today, the Heart Rhythm Society (HRS) released a framework outlining criteria for establishing an Atrial Fibrillation (AF) ...

Oral semaglutide (Rybelsus) can be tied to a near halving of incident Afib, according to a meta-analysis of 26 randomized ...

HeartBeam (Nasdaq:BEAT) today announced that a study of its synthesized 12-lead electrocardiogram (ECG) met its clinical ...

The benefit of GLP-1 therapy couldn’t be explained by weight loss, suggesting that some pleiotropic effects may be at work.

Results of the VANISH-2 trial, building on prior research, further upheld superiority of catheter ablation over ...

Atraverse Medical, a San Diego-based medical device company pioneering universally-compatible transseptal access technology, announced to ...